Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 2021

View Archived Issues

Phase I trial evaluates [11C]YJH-08 PET imaging of GR expression in metastatic prostate cancer

Camino studies SBP-9330 in first-in-human trial for smoking cessation

New Toll-like receptor 7 agonists identified at Bristol Myers Squibb

Vertex Pharmaceuticals presents new apolipoprotein L1 inhibitors

New CREB-2 inhibitors discovered at Evotec International

Memorial Sloan-Kettering Cancer Center describes prodrugs useful in adoptive cell therapy

Mutational profiling gives clues to development, new puzzles about disease

Blade receives IND clearance for phase I study of cudetaxestat for IPF

Data presented for Almirall's JAK inhibitor LAS-200019

Janssen targets DHODH with new compounds for acute myelogenous leukemia

HUTCHMED begins phase Ib/II study of fruquintinib with tislelizumab in TNBC and endometrial cancer

New phase I/II trial investigates RVU-120 in relapsed/refractory metastatic or advanced solid tumors

CPI-613 advances into phase II evaluation in biliary tract cancer

Phase II trial of izokibep in ankylosing spondylitis commences dosing

Epeleuton shows promise in hamster model for SARS-CoV-2 infection

Mutation in RAPGEF1 gene tied to global developmental delay syndrome

Phase II study of SHR-0302 in alopecia areata meets primary efficacy endpoint

Studies reveal efficacy and mechanism of SARS-CoV-2-neutralizing antibody SC-31